Skip to main content

Table 5 Treatment and outcome of patients with C. neoformans versus C. curvatus/C. laurentii meningitis

From: Comparison of clinical and biological characteristics of HIV-infected patients presenting Cryptococcus neoformans versus C. curvatus/C. laurentii meningitis

Variable Cryptococcal species p
C. neoformans
na (%)b
C. curvatus/C. laurentii
na (%)b
Scheme of antifungal agents 0.09
 AFFc 22 (95.7) 4 (66.7)  
 Fluconazole 0 1 (33.3)  
Average hospital stay (day) 9.9 ± 6.01 12.4 ± 5.27 0.65
Therapeutic outcome 0.16
 Goodd 10 (43.5) 5 (83.3)  
 Bade 13 (56.5) 1 (16.7)  
  1. aWith available data
  2. bPercentage of columns calculated for each group
  3. cAmphotericin B + 5-flucytosine + fluconazole
  4. dRecovery and discharge from hospital
  5. eDeath, status quo, discharge against medical advice or transfer due to complications